Subramanian Sanjay 4
4 · Ocugen, Inc. · Filed Jan 5, 2022
Insider Transaction Report
Form 4
Ocugen, Inc.OCGN
Subramanian Sanjay
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-03+454,007→ 454,007 totalExercise: $4.72Exp: 2032-01-03→ Common Stock (454,007 underlying) - Award
Common Stock
2022-01-03+125,534→ 161,125 total
Footnotes (2)
- [F1]Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Ocugen Inc.'s (the "Company's") common stock. The restricted stock units vest annually in three equal installments commencing on January 3, 2023, subject to continued employment with the Company on the applicable vesting dates. The restricted stock units will be settled on each applicable vesting date in shares of the Company's common stock.
- [F2]The option vests annually in equal installments over three years commencing on January 3, 2023, subject to continued employment with the Company on the applicable vesting dates.